Lista de obras - Virginia Ferraresi - Dominio Público Uruguay

153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients

scientific article published on 21 November 2011

18F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: the added value of tumor grading

artículo científico publicado en 2019

A multiplanar complex resection of a low-grade chondrosarcoma of the distal femur guided by K-wires previously inserted under CT-guide: a case report

artículo científico publicado en 2014

A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.

artículo científico publicado en 2010

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer.

artículo científico publicado en 2007

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

artículo científico

An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma.

artículo científico publicado en 2009

Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy.

artículo científico publicado en 2009

Bilateral spontaneous pneumothorax and massive pneumomediastinum under Pazopanib therapy.

artículo científico publicado en 2015

Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women

artículo científico publicado en 1999

Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two cases.

artículo científico publicado en 2005

Chemotherapeutically induced cutaneous tuberculosis after BCG injection in a patient with pelvic osteosarcoma

artículo científico

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

artículo científico publicado en 2009

Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients

artículo científico publicado en 2010

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma

artículo científico publicado en 2014

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

artículo científico publicado en 2015

Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.

artículo científico publicado en 2010

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

artículo científico publicado en 2013

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

artículo científico publicado en 2013

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

artículo científico publicado en 2014

Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

scholarly article published in Cancer Immunology, Immunotherapy

Familial Kaposi's Sarcoma in HHV8 infected subjects presenting the G-174C allele of the IL-6 promoter: a possible role for EBV?

artículo científico publicado en 2014

Gemcitabine at fixed dose-rate in patients with advanced soft-tissue sarcomas: a mono-institutional phase II study

artículo científico publicado en 2008

Giant cell tumor of bone in a patient with diagnosis of primary hyperparathyroidism: a challenge in differential diagnosis with brown tumor.

artículo científico publicado en 2013

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance

artículo científico publicado en 2018

Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial

artículo científico publicado en 2017

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

artículo científico publicado en 2017

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.

artículo científico publicado en 1999

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

article

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

artículo científico publicado en 2017

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

artículo científico publicado en 2020

Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).

artículo científico publicado en 2014

Phase II study of imatinib in advanced chordoma

artículo científico publicado en 2012

Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer.

artículo científico publicado en 1994

Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.

artículo científico publicado en 2016

Precision diagnostics of Ewing's sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts.

artículo científico publicado en 2018

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

artículo científico publicado en 2016

Radiation recall dermatitis in course of epidemic Kaposi's sarcoma

artículo científico publicado en 2013

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

artículo científico publicado en 2014

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.

artículo científico publicado en 2014

Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study.

artículo científico publicado en 2000

Weekly schedule of vinorelbine in pretreated breast cancer patients

scientific article published on 01 February 2000

miR-181c associates with tumor relapse of high grade osteosarcoma

artículo científico publicado en 2015

Lista de obras de Virginia Ferraresi

153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients

18F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: the added value of tumor grading

A multiplanar complex resection of a low-grade chondrosarcoma of the distal femur guided by K-wires previously inserted under CT-guide: a case report

A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer.

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma.

Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy.

Bilateral spontaneous pneumothorax and massive pneumomediastinum under Pazopanib therapy.

Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women

Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two cases.

Chemotherapeutically induced cutaneous tuberculosis after BCG injection in a patient with pelvic osteosarcoma

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Familial Kaposi's Sarcoma in HHV8 infected subjects presenting the G-174C allele of the IL-6 promoter: a possible role for EBV?

Gemcitabine at fixed dose-rate in patients with advanced soft-tissue sarcomas: a mono-institutional phase II study

Giant cell tumor of bone in a patient with diagnosis of primary hyperparathyroidism: a challenge in differential diagnosis with brown tumor.

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance

Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).

Phase II study of imatinib in advanced chordoma

Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer.

Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.

Precision diagnostics of Ewing's sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts.

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

Radiation recall dermatitis in course of epidemic Kaposi's sarcoma

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.

Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study.

Weekly schedule of vinorelbine in pretreated breast cancer patients

miR-181c associates with tumor relapse of high grade osteosarcoma